找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Chemotherapy and Urological Malignancy; A. S. D. Spiers (Professor of Medicine) Book 1982 Springer-Verlag Berlin Heidelberg 1982 Urogenita

[复制链接]
查看: 25574|回复: 49
发表于 2025-3-21 16:55:35 | 显示全部楼层 |阅读模式
书目名称Chemotherapy and Urological Malignancy
编辑A. S. D. Spiers (Professor of Medicine)
视频videohttp://file.papertrans.cn/225/224969/224969.mp4
丛书名称Clinical Practice in Urology
图书封面Titlebook: Chemotherapy and Urological Malignancy;  A. S. D. Spiers (Professor of Medicine) Book 1982 Springer-Verlag Berlin Heidelberg 1982 Urogenita
描述Chemotherapy for malignant disease has brought about many rapid and often spectacular improvements in the survival rate of some groups of patients. Yet enthusiasm for these successes has, in part, been offset by the problems in evaluating responses to treatment and by the disappointment of failing to check the progress of still so many other tumours. These reactions will be no surprise to the medical historian but perhaps the expectations from scientific progress nowadays sometimes demand more than can reasonably be expected. Another expectation is that any review of chemotherapy is com­ pletely up to date, even prophetic. Such is the expansion of the subject that new drugs and trial results are continually being reported but it is this very mass of information that creates its own problems and makes many clinicians despair of finding a balanced judgement on all of this information. This was the challenge accepted by Professor Spiers. He then gathered together a group of colleagues who are amongst the acknowledged leaders in the field of chemotherapy for urological tumours, all of whom have made important contributions to this subject. However, each chapter is not merely a record o
出版日期Book 1982
关键词Urogenitalkrebs; Zytostatikum; cancer; carcinoma; chemotherapy; kidney; prostate; tumor
版次1
doihttps://doi.org/10.1007/978-1-4471-1332-4
isbn_softcover978-1-4471-1334-8
isbn_ebook978-1-4471-1332-4Series ISSN 0177-8994
issn_series 0177-8994
copyrightSpringer-Verlag Berlin Heidelberg 1982
The information of publication is updating

书目名称Chemotherapy and Urological Malignancy影响因子(影响力)




书目名称Chemotherapy and Urological Malignancy影响因子(影响力)学科排名




书目名称Chemotherapy and Urological Malignancy网络公开度




书目名称Chemotherapy and Urological Malignancy网络公开度学科排名




书目名称Chemotherapy and Urological Malignancy被引频次




书目名称Chemotherapy and Urological Malignancy被引频次学科排名




书目名称Chemotherapy and Urological Malignancy年度引用




书目名称Chemotherapy and Urological Malignancy年度引用学科排名




书目名称Chemotherapy and Urological Malignancy读者反馈




书目名称Chemotherapy and Urological Malignancy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:06:48 | 显示全部楼层
Chemotherapy for Advanced Urothelial Tract Tumors,. 1979). In the Western Hemisphere, a strong link to various chemical carcinogens as inciting or promoting agents has been firmly established (Cohen 1979) and it is therefore surprising that the incidence of bladder cancer has not increased significantly (thus far) in the United States during the past 10–20 years.
发表于 2025-3-22 03:54:19 | 显示全部楼层
发表于 2025-3-22 07:25:59 | 显示全部楼层
发表于 2025-3-22 09:04:40 | 显示全部楼层
https://doi.org/10.1007/978-3-642-20086-1herapy, it will be helpful to review the pathology of superficial bladder cancer, critical factors in endoscopic management, and the current concepts regarding the etiology of the high incidence of subsequent tumors.
发表于 2025-3-22 14:04:59 | 显示全部楼层
发表于 2025-3-22 19:41:19 | 显示全部楼层
发表于 2025-3-22 21:13:30 | 显示全部楼层
发表于 2025-3-23 03:43:13 | 显示全部楼层
Intravesical Chemotherapy for Superficial Bladder Cancer,herapy, it will be helpful to review the pathology of superficial bladder cancer, critical factors in endoscopic management, and the current concepts regarding the etiology of the high incidence of subsequent tumors.
发表于 2025-3-23 06:32:08 | 显示全部楼层
0177-8994 tients. Yet enthusiasm for these successes has, in part, been offset by the problems in evaluating responses to treatment and by the disappointment of failing to check the progress of still so many other tumours. These reactions will be no surprise to the medical historian but perhaps the expectatio
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-23 18:40
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表